Latest Content

The FDA granted breakthrough therapy designation to sonrotoclax for adults with relapsed or refractory mantle cell lymphoma, based on phase 1/2 data.

Dr. Komal Jhaveri says Breast Cancer Awareness Month should move beyond pink ribbons to drive early detection, research and equitable care.

I was sitting in my oncologist's office, listening to her explain my treatment plan, when a strange thought crossed my mind: this feels familiar.

While Breast Cancer Awareness Month raises funds and awareness, for survivors, it can painfully remind them of all they’ve endured.

The challenges of being diagnosed with a rare cancer are real, but so is the strength that comes from thriving through it.

Dr. Evan Garfein explains how 3D printing and tissue-engineered implants could make breast reconstruction safer and less taxing on the body.

Brittney Nichols highlights the need for early detection and stresses that lung cancer is not only caused by smoking; anyone can develop the disease.

The FDA has granted breakthrough therapy designation to ficerafusp alfa with Keytruda for some patients with head and neck squamous cell carcinoma.

CURE spoke with Dr. Komal Jhaveri about the findings of the EMBER-3 clinical trial.

CURE spoke with melanoma survivor Betsy Hamlin about her experience with subcutaneous Keytruda in a clinical trial.

Dr. Evan Garfein discussed OnPlant, a 3D breast model, and stressed timely reconstructive care for all patients during Breast Cancer Awareness Month.

Dr. Ravi Munver discusses how minimally invasive techniques allow patients to preserve kidney function and practical guidance for navigating treatment.

This guide provides a supportive overview of stage 2 melanoma, covering diagnosis, treatment options, and key questions for your medical team.